Cancer Clinical Trials Financial Reimbursement Program

RecruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

July 12, 2022

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2027

Conditions
Cancer Clinical Trials
Interventions
BEHAVIORAL

Survey / Interview Group

Patients with any cancer type who are informed that they may be eligible for participation in any phase therapeutic cancer clinical trial by their treating physician (typically a clinical oncologist) will be provided information about the Financial Reimbursement Program. Patients who enroll to therapeutic cancer clinical trial will be eligible for the reimbursement program and offered an opportunity to participate in this study.

Trial Locations (1)

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

Cancer Prevention Research Institute of Texas

OTHER

lead

University of Texas Southwestern Medical Center

OTHER